Summary: Circadian Health, a value-based specialty care organization focused on virtual care for cardiovascular, pulmonary, endocrinology, and sleep health, secured a $7.5 million investment led by HC9 Ventures to expand its partnerships with major health plans and providers. This funding will accelerate Circadian’s efforts in making specialty care more accessible, particularly for vulnerable populations, through in-home diagnostics and telemedicine.
Key Takeaways:
- Significant Investment: Circadian Health secured a $7.5 million investment led by HC9 Ventures, with additional strategic investment from Memorial Hermann Health System, to expand its value-based specialty care services.
- Focus on Specialty Care: Circadian Health is focused on providing virtual care for cardiovascular, pulmonary, endocrinology, and sleep health, areas often overlooked in value-based care due to their complexity.
- Scaling Partnerships: The investment will help Circadian strengthen relationships with large risk-bearing health plans and providers, making specialty care more integrated and accessible.
Circadian Health, a value-based specialty care organization that provides virtual care in the cardiovascular, pulmonary, endocrinology, and sleep care spaces, has garnered a $7.5 million investment led by HC9 Ventures. The investment will accelerate its relationships with the largest risk-bearing health plans and providers.
Alongside HC9 Ventures, Memorial Hermann Health System, a not-for-profit health system in Southeast Texas, made a strategic investment in Circadian.
“Value-based care has long focused just on primary and turned a blind eye to specialty because it was too complex, too daunting…but that’s no longer the case,” says Sean Heyniger, CEO of Circadian, in a release. “The last couple of years have seen Circadian burst on to the scene. We’ve known the HC9 team for a long time and infusing their operational acumen with Circadian’s vision is symmetry at its finest. We are thrilled to scale rapidly over the next 12 months.”
Richard Lungen, general partner of HC9 Ventures, says in a release, “Circadian’s leadership team are highly accomplished executives who’ve been deeply involved in the evolution of telemedicine and the sleep market since its earliest years. Having the opportunity to collaborate on a seismic shift in virtual care was a logical one for our team. Circadian’s ability to shift virtual care E&M and diagnostics to the home is impressive, making specialty care significantly more convenient, something we all know the consumer of healthcare is demanding more regularly. We are excited for the healthcare market, including major payers, risk-bearing providers, employers, and more to embrace Circadian.”
As a key early step to make value-based specialty care possible, Circadian partnered with React Health in 2023, enabling a vertically integrated specialty care bundle. “With access to in-home diagnostic testing and DME coordinated medical device deployment, Circadian is offering a cardiometabolic home for vulnerable and disadvantaged populations,” says Chuck Hector, president and chief commercial officer of Circadian, in a release. “We are a welcomed addition to the toolkits of risk-bearing entities in reaching more patients.”
ID 209277209 © Milosdrn | Dreamstime.com
Leave a Reply